Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 3
Abstract
The study examined the sensitivity of DPI in vitro performance to formulation and device changes. Rotahaler/Rotacaps was selected as the reference DPI drug product, and Aerolizer was selected as the test device. Since the test device was recognized to have much greater efficiency of dispersion, simple modifications to both formulation and device were made in an effort to provide a closer match to the in vitro performance of the reference product. The modifications included varying the drug and lactose particle sizes and/or lactose fine particle content in the test formulations, as well as lowering the specific resistance of the test device. These modifications were intended to address variables important for drug product performance for a defined experimental design and were not intended to mimic the extensive formulation and device design strategies that are employed in an industrial setting. Formulation and device modifications resulted in a modified test product that approached the reference product in the in vitro performance.
Authors and Affiliations
Wallace P. Adams, Sau L. Lee, Robert Plourde, Robert A. Lionberger, Craig M. Bertha, William H. Doub, Jean-Marc Bovet, Anthony J. Hickey
Keywords
Related Articles
- EP ID EP681229
- DOI 10.1208/s12248-012-9352-7
- Views 68
- Downloads 0
A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs
Fetal RBCs are produced during a period of very rapid growth and stimulated erythropoiesis under hypoxic intrauterine conditions. Fetal RBC life span varies with gestational age (GA) and is shorter than that in healthy a...
Regulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules
The ATP-binding cassette transport proteins (ABC transporters) represent important determinants of drug excretion. Protective or excretory tissues where these transporters mediate substrate efflux include the kidney prox...
Risk Assessment of Drug Interaction Potential and Concomitant Dosing Pattern on Targeted Toxicities in Pediatric Cancer Patients
This investigation evaluated the impact of potential drug interactions on the incidence of reported toxicities seen with common dosing patterns in children with cancer, with the intent of being able to screen and reduce...
Challenges in the transition to model-based development
Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics
Opioids are widely used in the treatment of severe pain. The clinical use of the opioids is limited by serious side effects such as respiratory depression, constipation, development of tolerance, and physical dependence...